pharma · Persistent Corneal Epithelial Defect (PCED) · Recent onset Type 1 Diabetes
Doppel Farmaceutici
Dompe' Farmaceutici S.p.A.
Doppel Farmaceutici clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli
- Founded
- 1994
- Employees
- 393
- Programs
- 11
- Drugs
- 14
- Patents
- 0
Doppel Farmaceutici projects
11 ClinicalTrials.gov programs sponsored by Doppel Farmaceutici.
Doppel Farmaceutici has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ICY-AKC-301
Dompe' Farmaceutici S.p.A.
Atopic Keratoconjunctivitis
1 trial -
NGF-PCED-301
Dompe' Farmaceutici S.p.A.
Persistent Corneal Epithelial Defect (PCED)
1 trial -
ICY0123
Dompe' Farmaceutici S.p.A.
Atopic keratoconjunctivitis (AKC)
1 trial -
Ladarixin, Placebo to match Ladarixin
Dompe' Farmaceutici S.p.A.
Recent onset Type 1 Diabetes
1 trial -
NGF-CP-201
Dompe' Farmaceutici S.p.A.
Spastic Cerebral Palsy
1 trial -
NGF0123
Dompe' Farmaceutici S.p.A.
Dry Eye
1 trial -
Reparixin, Placebo - Tablet for oral use
Dompe' Farmaceutici S.p.A.
Acute Respiratory Distress Syndrome
1 trial -
TACHIPIRINA compresse for Chronic low back pain
Dompe' Farmaceutici S.p.A.
Chronic low back pain
1 trial -
Vehicle, Cenegermin
Dompe' Farmaceutici S.p.A.
Subacute Moderate to Severe Traumatic Brain Injury (TBI)
1 trial -
DF2755A-HV-101
Dompe' Farmaceutici S.p.A.
interstitial cystitis/bladder pain syndrome
1 trial -
LDX-HV-101
Dompe' Farmaceutici S.p.A.
Ocular inflammatory conditions
1 trial
Frequently asked questions
How many clinical projects does Doppel Farmaceutici have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.